These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 19710920)

  • 41. TST, QuantiFERON-TB Gold test and T-SPOT.TB test for detecting latent tuberculosis infection in patients with rheumatic disease prior to anti-TNF therapy.
    Sargın G; Şentürk T; Ceylan E; Telli M; Çildağ S; Doğan H
    Tuberk Toraks; 2018 Jun; 66(2):136-143. PubMed ID: 30246657
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the tuberculin skin test and the interferon-gamma release assay for TB screening in French healthcare workers.
    Tripodi D; Brunet-Courtois B; Nael V; Audrain M; Chailleux E; Germaud P; Naudin F; Muller JY; Bourrut-Lacouture M; Durand-Perdriel MH; Gordeeff C; Guillaumin G; Houdebine M; Raffi F; Boutoille D; Biron C; Potel G; Roedlich C; Geraut C; Schablon A; Nienhaus A
    J Occup Med Toxicol; 2009 Nov; 4():30. PubMed ID: 19948042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tuberculin skin testing to assess the occupational risk of Mycobacterium tuberculosis infection among health care workers in Abidjan, Côte d'Ivoire.
    Kassim S; Zuber P; Wiktor SZ; Diomande FV; Coulibaly IM; Coulibaly D; Kadio A; Yapi A; Touré KC; Blekou PB; Irié B; Greenberg AE; Binkin NJ
    Int J Tuberc Lung Dis; 2000 Apr; 4(4):321-6. PubMed ID: 10777080
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and risk factors for latent tuberculosis infection among health care workers in Georgia.
    Mirtskhulava V; Kempker R; Shields KL; Leonard MK; Tsertsvadze T; del Rio C; Salakaia A; Blumberg HM
    Int J Tuberc Lung Dis; 2008 May; 12(5):513-9. PubMed ID: 18419886
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence and risk factors for tuberculosis infection among personnel in two hospitals in Viet Nam.
    Powell K; Han D; Hung NV; Vu T; Sy DN; Trinh TT; Le TC; Do K; Oeltmann JE; Whitehead S
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1643-9. PubMed ID: 22118172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Screening for tuberculosis infection using whole-blood interferon-gamma and Mantoux testing among Japanese healthcare workers.
    Harada N; Nakajima Y; Higuchi K; Sekiya Y; Rothel J; Mori T
    Infect Control Hosp Epidemiol; 2006 May; 27(5):442-8. PubMed ID: 16671023
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relating Tuberculosis (TB) Contact Characteristics to QuantiFERON-TB-Gold and Tuberculin Skin Test Results in the Toronto Pediatric TB Clinic.
    Rose W; Read SE; Bitnun A; Rea E; Stephens D; Pongsamart W; Kitai I
    J Pediatric Infect Dis Soc; 2015 Jun; 4(2):96-103. PubMed ID: 26407408
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.
    Kurti Z; Lovasz BD; Gecse KB; Balint A; Farkas K; Morocza-Szabo A; Gyurcsanyi A; Kristof K; Vegh Z; Gonczi L; Kiss LS; Golovics PA; Lakatos L; Molnar T; Lakatos PL
    J Gastrointestin Liver Dis; 2015 Dec; 24(4):467-72. PubMed ID: 26697573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the interferon-gamma release assay in healthcare workers.
    Nienhaus A; Schablon A; Bâcle CL; Siano B; Diel R
    Int Arch Occup Environ Health; 2008 Jan; 81(3):295-300. PubMed ID: 17605033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of interferon gamma release assay & tuberculin skin tests for diagnosis of latent tuberculosis in patients on maintenance haemodialysis.
    Agarwal SK; Singh UB; Zaidi SH; Gupta S; Pandey RM
    Indian J Med Res; 2015 Apr; 141(4):463-8. PubMed ID: 26112848
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of interferon-gamma release assays in the diagnosis of recent tuberculosis infection in health care workers.
    Casas I; Latorre I; Esteve M; Ruiz-Manzano J; Rodriguez D; Prat C; García-Olivé I; Lacoma A; Ausina V; Domínguez J
    PLoS One; 2009 Aug; 4(8):e6686. PubMed ID: 19701460
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children.
    Connell TG; Ritz N; Paxton GA; Buttery JP; Curtis N; Ranganathan SC
    PLoS One; 2008 Jul; 3(7):e2624. PubMed ID: 18612425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tests for latent tuberculosis in people with ESRD: a systematic review.
    Rogerson TE; Chen S; Kok J; Hayen A; Craig JC; Sud K; Kable K; Webster AC
    Am J Kidney Dis; 2013 Jan; 61(1):33-43. PubMed ID: 23068425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of interferon-gamma release assay for systematic tuberculosis screening of healthcare workers in low-incidence countries.
    Kowada A; Takasaki J; Kobayashi N
    J Hosp Infect; 2015 Feb; 89(2):99-108. PubMed ID: 25559158
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Results and significance of a baseline tuberculin skin test programme among health care workers in a hospital setting].
    Gerbaudo L; Violante B
    Med Lav; 2007; 98(3):221-31. PubMed ID: 17598350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparing an Interferon Gamma Release Assay with the Tuberculin Skin Test During Pregnancy: Implications for Tuberculosis Screening During Prenatal Care.
    Molina R; Venkatesh K; Schantz-Dunn J; Meadows A; Nour N; Diouf K
    Matern Child Health J; 2016 Jun; 20(6):1314-20. PubMed ID: 26645617
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon-gamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients.
    Triverio PA; Bridevaux PO; Roux-Lombard P; Niksic L; Rochat T; Martin PY; Saudan P; Janssens JP
    Nephrol Dial Transplant; 2009 Jun; 24(6):1952-6. PubMed ID: 19164327
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Latent tuberculosis infection among health-care workers using Quantiferon-TB Gold-Plus in a country with a low burden for tuberculosis: prevalence and risk factors.
    Almohaya A; Aldrees A; Akkielah L; Hashim AT; Almajid F; Binmoammar T; Barry MA
    Ann Saudi Med; 2020; 40(3):191-199. PubMed ID: 32493098
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.